TABLE 2.
Metabolic pathways of QRKSG during the treatment of NS.
NO | Pathways | Raw p | -log(p) | Impact | Label |
---|---|---|---|---|---|
1 | D-Glutamine and D-glutamate metabolism | 2.30 × 10–3 | 2.64 | 0.5 | a |
2 | Alanine, aspartate and glutamate metabolism | 4.90 × 10–3 | 2.31 | 0.31 | b |
3 | Arginine and proline metabolism | 8.43 × 10–2 | 1.07 | 0.2 | c |
4 | Arginine biosynthesis | 6.12 × 10–4 | 3.21 | 0.18 | d |
5 | Pentose phosphate pathway | 3.13 × 10–2 | 1.5 | 0.09 | e |
6 | Amino sugar and nucleotide sugar metabolism | 3.85 × 10–1 | 0.41 | 0.05 | f |
7 | Citrate cycle (TCA cycle) | 2.30 × 10–1 | 0.64 | 0.03 | g |
8 | Glutathione metabolism | 4.90 × 10–3 | 2.31 | 0.03 | h |
9 | Nitrogen metabolism | 2.30 × 10–3 | 2.64 | 0 | i |
10 | Butanoate metabolism | 1.50 × 10–2 | 1.82 | 0 | j |